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Introduction Cannabinoids such as Δ9–tetrahydrocannabinol
(Δ9–THC) are neuroprotective in animal and cell culture
models of Parkinson’s disease (PD). In a PD cell culture model
we recently demonstrated that Δ9–THC is neuroprotective
through activation of the nuclear receptor peroxisomal prolifer-
ator–activated receptor γ (PPARγ). Furthermore, activation by
speciﬁc agonists rosiglitazone and pioglitazone, has also been
found neuroprotective. PPARγ is a nuclear receptor whose acti-
vation can lead to the expression of proteins involved in the de
novo synthesis of mitochondria. One such protein is the PPARγ
co–activator 1 α (PGC1α) as it co–activates NRF–1 mediated
gene expression which is essential for the production of nuclear
encoded, mitochondrial proteins. Here we investigate the effect
of Δ9–THC and pioglitazone on mitochondrial biogenesis.
Methods SH–SY5Y neuroblastoma cells were differentiated
with retinoic acid and exposed to the PD relevant mitochondrial
complex 1 inhibitor, MPP+. Δ9–THC and pioglitazone were
co–administered with the minimum concentration of the speciﬁc
PPARγ antagonist T0070907 able to block the protective effect
of each compound respectively for 48 hours. The production of
reactive oxygen species was then measured, proteins were
extracted for Western blotting and total DNA was extracted to
determine mitochondrial DNA (mtDNA) content by QPCR.
Results Δ9–THC resulted in signiﬁcant inhibition of MPP+
induced oxidative stress which was completely reversed by
T0070907 whereas pioglitazone induced reduction in oxidative
stress did not seem to be PPARγ dependent. Accordingly, both
pioglitazone and Δ9–THC were able to restore MPP+ induced
down–regulation of PGC1α, to the level of untreated control.
This effect was inhibited by T0070907 in the case of Δ9–THC
but not pioglitazone. Whilst NRF1 expression remained
unaffected by all treatments, the mitochondrial transcription
factor (tfam) which is necessary for mtDNA replication was
reduced with MPP+ and up–regulated by Δ9–THC only.
Similarly, mtDNA content and the mitochondrial marker COX4
were only increased by Δ9–THC.
Conclusions Even though Δ9–THC and pioglitazone are both
protective against MPP+ only Δ9–THC induces PPARγ depend-
ent mitochondrial biogenesis, a mechanism that may be beneﬁ-
cial for the treatment of PD.
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